Definition
The process by which information encoded in a gene is used to synthesize functional gene products, typically measured as mRNA or protein levels.
Related Claims
- Most random gene signatures associate with breast cancer outcome
- Proliferation confounds gene signature outcome association
- Cell cycle gene removal fails to eliminate proliferation confounding
- Gene signature outcome association questionably indicates biological relevance
- Primary glioblastomas contain inherent variability in oncogenic signaling expression
- Proliferation and immune response programs vary across individual glioblastoma cells
- Hypoxia-related transcriptional programs are variably expressed in glioblastoma cells
- CaSpER algorithm uses expression and BAF values to estimate CNV events
- Gene expression scales proportionally to whole chromosome copy number in chromosomally unstable CSCs
- Copy number alterations account for most differential gene expression between NSCs and glioblastoma CSCs
- Neural stem cells and glioblastoma CSCs have distinct transcriptome profiles
- Gene expression levels can computationally infer large-scale copy number variations in chromosomally unstable cells
- SNPs capture majority of genetic variation affecting gene expression
- Copy number variations account for substantial but secondary gene expression variation
- SNP and CNV signals show minimal overlap in gene expression associations
- Interrogating both SNPs and CNVs is necessary for understanding complex phenotypes
Synthesis
Gene expression, measured as mRNA or protein levels synthesized from genetic information, serves as both a direct readout of genetic architecture and a key intermediate phenotype linking genomic variation to biological outcomes. Mechanistically, gene expression levels are shaped by multiple layers of genetic variation, with single nucleotide polymorphisms accounting for approximately 84% of detectable heritable variation in transcript abundance while copy number variations contribute a substantial but secondary 18%, with minimal overlap between these two sources indicating they operate through distinct regulatory mechanisms. In chromosomally unstable cancer cells, gene expression exhibits a proportional scaling relationship with whole chromosome copy number, enabling computational inference of large-scale genomic alterations from transcriptional data alone and revealing how genomic instability directly manifests in the transcriptome. However, the biological interpretation of gene expression signatures remains deeply contested, particularly in cancer contexts where most random gene signatures—even those derived from unrelated biological processes—significantly associate with clinical outcomes, a phenomenon largely explained by confounding from proliferation-related transcriptional programs that cannot be adequately controlled by simply removing canonical cell cycle genes, raising fundamental questions about whether statistical associations between expression patterns and disease outcomes reliably indicate biological relevance.